Top Stories : Aeterna Zentaris (NASDAQ:AEZS), Synageva BioPharma Corp. (NASDAQ:GEVA), TC PipeLines (NYSE:TCP), Standard Motor Products Inc. (NYSE:SMP), Hospitality Properties (NYSE:HPT)

Aeterna Zentaris Inc. (NASDAQ:AEZS) on Aug. 7 reported financial and operating results as at and for the second quarter ended June 30, 2014. Net loss for the three-month period ended June 30, 2014 was $5.0 million compared to a net income of $9.3 million for the same period in 2013. The decrease in net income is due largely to lower net income from discontinued operations … Continue reading Top Stories : Aeterna Zentaris (NASDAQ:AEZS), Synageva BioPharma Corp. (NASDAQ:GEVA), TC PipeLines (NYSE:TCP), Standard Motor Products Inc. (NYSE:SMP), Hospitality Properties (NYSE:HPT)

Jayne Crisman09/0309/03

Stocks to Watch : Texas Instruments Inc. (NASDAQ:TXN), QLogic Corp. (NASDAQ:QLGC), Parkervision Inc. (NASDAQ:PRKR), TC PipeLines, LP (NYSE:TCP), Trio-Tech International (NYSEMKT:TRT)

The Board of Directors of Texas Instruments Inc. (NASDAQ:TXN) declared a quarterly cash dividend of $0.34 per share of common stock, payable November 17, 2014, to stockholders of record on October 31, 2014. Texas Instruments Inc. (NASDAQ:TXN) belongs to Technology sector. Its net profit margin is 18.10% and weekly performance is -5.28%. On last trading day company shares ended up $43.59. Texas Instruments Inc. (NASDAQ:TXN) … Continue reading Stocks to Watch : Texas Instruments Inc. (NASDAQ:TXN), QLogic Corp. (NASDAQ:QLGC), Parkervision Inc. (NASDAQ:PRKR), TC PipeLines, LP (NYSE:TCP), Trio-Tech International (NYSEMKT:TRT)

Mark DeFrance10/1710/17

Stocks in Focus : BIND Therapeutics (NASDAQ:BIND), Bristol-Myers Squibb (NYSE:BMY), TC PipeLines (NYSE:TCP), Entergy Corporation (NYSE:ETR), Rigel Pharmaceuticals (NASDAQ:RIGL)

BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, today announced the appointments of Eric K. Rowinsky, M.D. and Amy W. Schulman to the company’s board of directors. Together the significant insights and expertise of these two industry leaders will help to guide BIND’s management team in the achievement of its business and development goals. BIND Therapeutics, … Continue reading Stocks in Focus : BIND Therapeutics (NASDAQ:BIND), Bristol-Myers Squibb (NYSE:BMY), TC PipeLines (NYSE:TCP), Entergy Corporation (NYSE:ETR), Rigel Pharmaceuticals (NASDAQ:RIGL)

Jayne Crisman10/0810/08

Stocks in Focus: BIND Therapeutics, Inc. (NASDAQ:BIND), Bristol-Myers Squibb Company (NYSE:BMY), TC PipeLines, LP (NYSE:TCP), Entergy Corporation (NYSE:ETR), Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)

BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, today announced the appointments of Eric K. Rowinsky, M.D. and Amy W. Schulman to the company’s board of directors. Together the significant insights and expertise of these two industry leaders will help to guide BIND’s management team in the achievement of its business and development goals. BIND Therapeutics, … Continue reading Stocks in Focus: BIND Therapeutics, Inc. (NASDAQ:BIND), Bristol-Myers Squibb Company (NYSE:BMY), TC PipeLines, LP (NYSE:TCP), Entergy Corporation (NYSE:ETR), Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)

Kristen Barton10/0810/08